Abeona Therapeutics Inc.

Historical 13F Holders

Symbol
ABEO
CUSIP
00289Y206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00289Y206 since 12/18/2024, largest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13G/A
10.0% 5/15/2026
Event 3/31/2026
Nantahala Capital Partners Limited Partnership 13G/A 5.8% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G 5.8% 7/17/2025
Event 6/30/2025
Orin Hirschman 13G
5.4% 4/28/2026
Event 3/31/2026
Funicular Funds, LP 13G
5.3% 4/6/2026
Event 3/27/2026
James Russell Revocable Trust 13G 5.3% 9/30/2025
Event 9/16/2025
Kaufman Daniel Louis 13G 5.2% 3/27/2026
Event 3/26/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Integrated Core Strategies (US) LLC 13G/A
1.7% 5/1/2025
Event 3/31/2025
Montanova Capital, LLC 13G/A
0.9% 8/14/2026
Event 6/30/2026
Adage Capital Management, L.P. 13G/A
0% 2/12/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 2.55 k $13.4 k
2026 Q2 138 44.5 M $276 M
2026 Q1 118 39.5 M $177 M
2025 Q4 115 38.9 M $205 M
2025 Q3 111 35.9 M $189 M
2025 Q2 104 34.9 M $198 M
2025 Q1 77 29.7 M $141 M
2024 Q4 71 30.6 M $170 M
2024 Q3 62 28.8 M $182 M
2024 Q2 62 34.2 M $145 M
2024 Q1 69 14.5 M $105 M
2023 Q4 59 16.4 M $82.2 M
2023 Q3 44 12.5 M $52.5 M
2023 Q2 41 9.39 M $37.9 M
2023 Q1 34 7.53 M $21.2 M
2022 Q4 43 8.23 M $28.7 M
2022 Q3 23 1.04 M $3.16 M
2022 Q2 1 34.8 k $169 k